Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects.
S H
SH
Snyder
I J
IJ
Reynolds
D000930:Antidiarrheals / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D001923:Brain Chemistry; D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D015220:Calcium Channels; D006220:Haloperidol / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D009132:Muscles / Q000032:analysis; D010880:Piperidines / Q000494:pharmacology; D011978:Receptors, Nicotinic / Q000187:drug effects* / Q000302:isolation & purification
D000930:Antidiarrheals; D014150:Antipsychotic Agents; D002121:Calcium Channel Blockers; D015220:Calcium Channels; D007473:Ion Channels; D010880:Piperidines; D011978:Receptors, Nicotinic; D006220:Haloperidol; D002118:Calcium